Insulet (PODD) Shares Outstanding (2010 - 2026)
Insulet's (PODD) quarterly Shares Outstanding (Entity) came in at $69.4 million in Q2 2026, down 1.48% on a YoY basis from $70.4 million in Q2 2025, and little changed quarter-over-quarter from $69.3 million in Q1 2026.
Analysis
Insulet (PODD) Shares Outstanding (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Shares Outstanding (Entity) for 17 consecutive years, with $69.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Shares Outstanding (Entity) fell 1.48% year-over-year to $69.4 million; the trailing twelve-month figure through Jun 2026 stood at $69.4 million (down 1.48% YoY), and the FY2025 full-year result was $70.4 million, changed 0.28% from the prior year.
- Shares Outstanding (Entity) held at $69.4 million in Q2 2026 per PODD's latest filing, from $69.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $70.4 million in Q2 2025 and bottomed at $69.3 million in Q1 2026.
- Historically, Shares Outstanding (Entity) has averaged $69.9 million across 5 years, with a median of $69.9 million in 2023.
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) grew 4.69% in 2022, then fell 1.56% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $69.5 million in 2022, then rose by 0.57% to $69.9 million in 2023, then rose by 0.41% to $70.2 million in 2024, then climbed by 0.28% to $70.4 million in 2025, then declined by 1.47% to $69.4 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $69.4 million, $69.3 million, and $70.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | 354.10 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 1.28 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | 383.50 Mn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 576.40 Mn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | 493.20 Mn |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | 382.20 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Insulet | 9.33 Bn | 8.79 Bn | 562.60 Mn | 69.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.30 Mn |
| Mar 31, 2026 | 69.99 Mn |
| Dec 31, 2025 | 70.35 Mn |
| Sep 30, 2025 | 70.37 Mn |
| Jun 30, 2025 | 70.39 Mn |
| Mar 31, 2025 | 70.27 Mn |
| Dec 31, 2024 | 70.08 Mn |
| Sep 30, 2024 | 70.12 Mn |
| Jun 30, 2024 | 70.06 Mn |
| Mar 31, 2024 | 69.96 Mn |
| Dec 31, 2023 | 69.75 Mn |
| Sep 30, 2023 | 69.82 Mn |
| Jun 30, 2023 | 69.74 Mn |
| Mar 31, 2023 | 69.58 Mn |
| Dec 31, 2022 | 69.38 Mn |
| Sep 30, 2022 | 69.42 Mn |
| Jun 30, 2022 | 69.36 Mn |
| Mar 31, 2022 | 69.25 Mn |
| Dec 31, 2021 | 67.70 Mn |
| Sep 30, 2021 | 68.87 Mn |